Latest Insider Transactions at Champions Oncology, Inc. (CSBR)
This section provides a real-time view of insider transactions for Champions Oncology, Inc. (CSBR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CHAMPIONS ONCOLOGY, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CHAMPIONS ONCOLOGY, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 31
2024
|
Joel Ackerman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
105,137
+5.13%
|
$315,411
$3.77 P/Share
|
|
Jan 12
2024
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.5%
|
$6,000
$6.5 P/Share
|
|
Jan 11
2024
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
2,000
+1.0%
|
$12,000
$6.27 P/Share
|
|
Jan 10
2024
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
2,944
+1.48%
|
$17,664
$6.31 P/Share
|
|
Jan 09
2024
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
3,000
+1.53%
|
$18,000
$6.25 P/Share
|
|
Jan 08
2024
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.52%
|
$6,000
$6.15 P/Share
|
|
Jan 05
2024
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
2,000
+1.05%
|
$12,000
$6.09 P/Share
|
|
Jan 04
2024
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
3,000
+1.58%
|
$18,000
$6.12 P/Share
|
|
Jan 03
2024
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
500
+0.27%
|
$2,500
$5.83 P/Share
|
|
Dec 21
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
2,500
+1.35%
|
$10,000
$4.92 P/Share
|
|
Dec 20
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
2,100
+1.15%
|
$8,400
$4.82 P/Share
|
|
Dec 19
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
5,000
+2.72%
|
$20,000
$4.75 P/Share
|
|
Oct 17
2023
|
Joel Ackerman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
114,552
+11.79%
|
$229,104
$2.1 P/Share
|
|
Oct 11
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
5,000
+2.97%
|
$30,000
$6.4 P/Share
|
|
Oct 10
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
1,100
+0.69%
|
$6,600
$6.41 P/Share
|
|
Oct 06
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
1,530
+0.97%
|
$9,180
$6.48 P/Share
|
|
Oct 05
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
2,000
+1.27%
|
$12,000
$6.47 P/Share
|
|
Oct 04
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
5,000
+3.16%
|
$30,000
$6.4 P/Share
|
|
Oct 03
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
2,500
+1.66%
|
$15,000
$6.3 P/Share
|
|
Sep 29
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
4,000
+2.25%
|
$24,000
$6.16 P/Share
|
|
Sep 28
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
5,000
+2.86%
|
$30,000
$6.22 P/Share
|
|
Sep 27
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
1,500
+0.9%
|
$7,500
$5.95 P/Share
|
|
Sep 26
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
5,000
+3.31%
|
$25,000
$5.65 P/Share
|
|
Sep 22
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
3,812
+2.63%
|
$19,060
$5.5 P/Share
|
|
Sep 21
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
5,000
+3.52%
|
$25,000
$5.51 P/Share
|
|
Sep 20
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
4,018
+2.95%
|
$20,090
$5.51 P/Share
|
|
Sep 19
2023
|
Daniel Newman Mendelson Director |
BUY
Open market or private purchase
|
Direct |
5,000
+3.76%
|
$25,000
$5.28 P/Share
|
|
Mar 17
2023
|
Ronnie Morris CEO |
BUY
Open market or private purchase
|
Direct |
12,382
+1.42%
|
$49,528
$4.04 P/Share
|
|
Oct 19
2022
|
Joel Ackerman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+1.13%
|
$50,001
$3.21 P/Share
|
|
Oct 12
2022
|
Philip P. Breitfeld Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,562
-19.57%
|
$24,934
$7.51 P/Share
|
|
Oct 12
2022
|
Philip P. Breitfeld Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+31.41%
|
$24,999
$3.21 P/Share
|
|
Oct 12
2022
|
David Sidransky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,562
-0.46%
|
$24,934
$7.51 P/Share
|
|
Oct 12
2022
|
David Sidransky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+1.07%
|
$24,999
$3.21 P/Share
|
|
Oct 12
2022
|
Scott R Tobin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.0%
|
$30,000
$3.21 P/Share
|
|
Oct 15
2021
|
David Sidransky Director |
BUY
Payment of exercise price or tax liability
|
Direct |
2,629
+0.34%
|
$26,290
$10.08 P/Share
|
|
Oct 15
2021
|
David Sidransky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+2.13%
|
$16,667
$1.59 P/Share
|
|
Oct 12
2021
|
Scott R Tobin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+33.33%
|
$10,000
$1.59 P/Share
|
|
Mar 23
2021
|
Philip P. Breitfeld Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,340
-32.16%
|
$14,740
$11.35 P/Share
|
|
Mar 23
2021
|
Philip P. Breitfeld Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,167
+50.0%
|
$12,501
$3.65 P/Share
|
|
Jan 19
2021
|
Abba David Poliakoff Director |
BUY
Payment of exercise price or tax liability
|
Direct |
8,873
+9.84%
|
$97,603
$11.53 P/Share
|
|
Jan 19
2021
|
Abba David Poliakoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+11.19%
|
$90,000
$3.41 P/Share
|
|
Dec 16
2020
|
Philip P. Breitfeld Director |
SELL
Open market or private sale
|
Direct |
31,443
-100.0%
|
$345,873
$11.35 P/Share
|
|
Oct 30
2020
|
Scott R Tobin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$50,000
$5.46 P/Share
|
|
Oct 16
2020
|
David Sidransky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,100
-1.33%
|
$90,900
$9.01 P/Share
|
|
Oct 16
2020
|
David Sidransky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+2.15%
|
$83,335
$5.46 P/Share
|
|
Mar 11
2020
|
Ronnie Morris CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
126,940
+5.86%
|
$634,700
$5.28 P/Share
|
|
Mar 11
2020
|
Battery Ventures Ix, L.P. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
409,791
+8.02%
|
$2,048,955
$5.28 P/Share
|
|
Mar 03
2020
|
Joel Ackerman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
126,940
+4.06%
|
$634,700
$5.28 P/Share
|
|
Feb 18
2020
|
Daniel Newman Mendelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+8.16%
|
$90,000
$3.42 P/Share
|
|
Feb 11
2020
|
Daniel Newman Mendelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
34,375
+25.0%
|
$171,875
$5.76 P/Share
|